Developing state-based and VA healthcare system expanded access pilot programs for MDMA- and psilocybin-assisted therapy for Veterans struggling with PTSD, depression, suicidality, and related complex co-morbidities.
Securing federal and state appropriations for pilot programs to fund the training of providers and treatment of Veterans
Streamlining the process for research of Schedule I Controlled Substances, such as ibogaine and 5-MeO-DMT, which Veterans are currently utilizing with high success rates in other countries.
Opening immediate access to MDMA- and psilocybin-assisted therapies through the federal Right to Try Clarification Act for a small subset of Veterans who are at serious risk of suicide and have exhausted all other options.